Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patients with folate receptor α-positive, platinum-resistant ovarian cancer: a randomised, open-label, phase 3 trial

Toon Van Gorp, Kathleen Moore, Gottfried E. Konecny, Alexandra Léary, Yolanda García-García, Susana Banerjee, Domenica Lorusso, Jung-Yun Lee, John W. Moroney, Giuseppe Caruso, Dagmara Klasa-Mazurkiewicz, Jacqueline M. Tromp, Lainie P. Martin, Shani Breuer, Charles A. Leath, David Cibula, S. John Weroha, Purificación Estévez-García, David M. O’Malley, Rowan Miller, Lan Coffman, Giuseppa Scandurra, Dominique Berton-Rigaud, Lingling Li, Erin Zagadailov, Elisabeth Diver, Olivier Trédan, Felix Hilpert